MedPath

a double blind randomized study on the effectiveness of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in dark irided hypermetropic children - effectiveness of cycloplegics

Conditions
refraction of the eye/ refractive state of the eye
MedDRA version: 9.1Level: LLTClassification code 10038264Term: Refraction disorder
Registration Number
EUCTR2007-003483-22-NL
Lead Sponsor
Medisch Centrum Haaglanden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
45
Inclusion Criteria

Healthy; not suffering from syndromes or diseases, 3 to 6 years (not attending groups three of the Dutch primary school system) old very dark irided hypermetropic children, possesing good accommodation, with no glasses prior or who did not wear their hypermetropic glasses since at least 4 weeks and able to fixate with each eye.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not healthy, e.g. suffering from syndromes or diseases, very dark irided hypermetorpic children, possessing good accommodation, aged 3 to 6 years. Or healthy very dark irided hypermetropic children, aged 3 to 6 years but visiting the third year of Dutch primary school. Hypoaccommodation. Wearing glasses. Not able to fixate with each eye.

E.g. children not possessing the inclusioncriteria mentioned in E.3

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath